Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Drug Failure”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableNot Yet RecruitingNCT07476846
What this trial is testing

RhTPO Dose Escalation vs Eltrombopag Switch in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 112
Large-scale testing (Phase 3)Study completedNCT00093470
What this trial is testing

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Megakaryoblastic LeukemiaAdult Acute Monocytic Leukemia+14 more
National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Ended earlyNCT00838578
What this trial is testing

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin Co., Ltd. 65
Testing effectiveness (Phase 2)Ended earlyNCT00351858
What this trial is testing

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
Neovii Biotech 40
Testing effectiveness (Phase 2)Study completedNCT03264404
What this trial is testing

Azacitidine and Pembrolizumab in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Susan E. Bates 36
Post-approval studies (Phase 4)Study completedNCT01066650
What this trial is testing

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente

Who this might be right for
Coronary Artery DiseaseAngina PectorisUnstable Angina Pectoris+2 more
Foundation of Cardiovascular Research and Education Enschede 1,391
Large-scale testing (Phase 3)Ended earlyNCT02322281
What this trial is testing

TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 149
Not applicableEnrolling By InvitationNCT06706986
What this trial is testing

A Global Registry On Second gEneration and Long-acting inTegrase inhibiTor fAilures

Who this might be right for
HIVTherapy Failure
UMC Utrecht 250
Not applicableStudy completedNCT02689895
What this trial is testing

Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens

Who this might be right for
HIV
University of Zimbabwe 50
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Testing effectiveness (Phase 2)Study completedNCT00940251
What this trial is testing

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs

Who this might be right for
Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents
Jyoti Clinical and Pathological Laboratory 26